ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

January 31, 2014

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002

NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants

January 29, 1988